We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

102 hedge funds and large institutions have $129M invested in VanEck Biotech ETF in 2020 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 28 increasing their positions, 16 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

271% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 7

112% more call options, than puts

Call options by funds: $1.37M | Put options by funds: $646K

77% more capital invested

Capital invested by funds: $73M → $129M (+$56.4M)

75% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 16

23% more funds holding

Funds holding: 83 → 102 (+19)

4.58% more ownership

Funds ownership: 22.78% → 27.36% (+4.6%)

Holders
102
Holders Change
+19
Holders Change %
+22.89%
% of All Funds
2.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
28
Reduced
16
Closed
7
Calls
$1.37M
Puts
$646K
Net Calls
+$723K
Net Calls Change
+$1.31M

Top Buyers

Rank Fund Capital Flow
1
PAG
Pinnacle Advisory Group
Maryland
+$17.7M
2
Morgan Stanley
Morgan Stanley
New York
+$3.36M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.25M
4
LPL Financial
LPL Financial
California
+$2.05M
5
BRC
BHF RG Capital
Arizona
+$1.67M

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$4.57M
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$440K
3
UBS Group
UBS Group
Switzerland
-$361K
4
SBH
Segall Bryant & Hamill
Illinois
-$251K
5
CG
Caprock Group
Idaho
-$209K
Name Holding Trade Value Shares
Change 		Change in
Stake
BPA
51
Beacon Pointe Advisors
California
$277K +$258K +1,700 New
B
52
Bailard
California
$265K – – –
IAA
53
Ironsides Asset Advisors
North Carolina
$263K – – –
TCM
54
Tufton Capital Management
Maryland
$252K -$15.2K -100 -6%
EDRH
55
Edmond de Rothschild Holding
Switzerland
$249K +$213K +1,400 +1,077%
RICHC
56
Renaissance Investment Consultants Holding Company
Pennsylvania
$232K +$208K +1,367 New
HFAS
57
Hummer Financial Advisory Services
Illinois
$230K +$214K +1,410 New
CG
58
Cutler Group
California
$228K +$213K +1,400 New
NWP
59
Northstar Wealth Partners
Connecticut
$225K +$210K +1,385 New
CB
60
Commerce Bank
Missouri
$212K +$198K +1,300 New
FANJ
61
Financial Architects (New Jersey)
New Jersey
$208K – – –
Creative Planning
62
Creative Planning
Kansas
$208K +$194K +1,279 New
BCV
63
Banque Cantonale Vaudoise
Switzerland
$137K +$128K +840 New
Citigroup
64
Citigroup
New York
$115K -$4.41K -29 -4%
AF
65
Advisornet Financial
Minnesota
$111K +$12.2K +80 +13%
Simplex Trading
66
Simplex Trading
Illinois
$108K +$101K +663 New
William Blair & Company
67
William Blair & Company
Illinois
$106K +$24.2K +159 +32%
AP
68
Advisors Preferred
Maryland
$98K +$51.5K +339 +132%
CAN
69
Cetera Advisor Networks
California
$95K +$89.1K +586 New
KTC
70
Kistler-Tiffany Companies
Pennsylvania
$88K +$1.37K +9 +2%
CT
71
Caldwell Trust
Florida
$85.5K – – –
NSIM
72
North Star Investment Management
Illinois
$68K – – –
TFA
73
Transamerica Financial Advisors
Florida
$67K +$61.7K +406 New
First Manhattan
74
First Manhattan
New York
$65K – – –
EIP
75
Ellis Investment Partners
Pennsylvania
$59K – – –
1 2
3
4 5

BBH Hedge Fund Activity: Q2 2020 in Review

102 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q2 2020, worth a combined $129M — up 77% from $73M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new BBH positions and 7 closed out — a net gain of 19 holders — while 28 added to existing stakes and 16 trimmed.

The largest buyer was Pinnacle Advisory Group, adding an estimated $17.7M. The largest seller was Bank of America, cutting an estimated $4.57M.

  • 102 institutional investors held VanEck Biotech ETF (BBH) as of Q2 2020, up from 83 in Q1 2020.
  • Funds reported $129M of VanEck Biotech ETF stock for Q2 2020, up 77% quarter-over-quarter.
  • 26 funds opened new VanEck Biotech ETF positions in Q2 2020 and 7 closed out, a net change of +19 holders.
  • The largest VanEck Biotech ETF buyer in Q2 2020 was Pinnacle Advisory Group, an estimated $17.7M added.
  • The largest VanEck Biotech ETF seller in Q2 2020 was Bank of America, an estimated $4.57M sold.

Based on aggregated 13F filings for Q2 2020.